Cargando…
Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative
ABSTRACT: Barriers to recovering the excess treatment costs associated with health research from local organisations in the United Kingdom can increase research costs, delay completion of high- quality studies and risk disenfranchising health trusts and patients from participation. The authors demon...
Autores principales: | Palmer, Rebecca, Harrison, Madeleine, Cross, Elizabeth, Enderby, Pam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748533/ https://www.ncbi.nlm.nih.gov/pubmed/26860107 http://dx.doi.org/10.1186/s13063-016-1208-5 |
Ejemplares similares
-
Clinical and cost effectiveness of computer treatment for aphasia post stroke (Big CACTUS): study protocol for a randomised controlled trial
por: Palmer, Rebecca, et al.
Publicado: (2015) -
Conjugated Linoleic Acid: good or bad nutrient
por: Gonçalves, Daniela C, et al.
Publicado: (2010) -
The mask, the aerosol, and the pandemic: The good, the bad, and the ugly
por: Maheshwari, Rajat D
Publicado: (2020) -
Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial
por: Palmer, Rebecca, et al.
Publicado: (2019) -
Cough cardiopulmonary resuscitation for bradycardia management: good or bad?
por: Gupta, Nishkarsh, et al.
Publicado: (2019)